Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001079973-09-000412
Filing Date
2009-04-29
Accepted
2009-04-29 17:28:57
Documents
4
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO 1 appy_10ka-123108.htm 10-K/A 210283
2 EXHIBIT 31.1 appy_10ka1-ex31x1.htm EX-31.1 9425
3 EXHIBIT 31.2 appy_10ka1-ex31x2.htm EX-31.2 9457
4 EXHIBIT 32 appy_10ka1-ex32.htm EX-32 5740
  Complete submission text file 0001079973-09-000412.txt   236403
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33675 | Film No.: 09780268
SIC: 2835 In Vitro & In Vivo Diagnostic Substances